Top

Published in:

Open Access 01-08-2017 | Review

The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension

Authors: Christopher H. Gibbons, Peter Schmidt, Italo Biaggioni, Camille Frazier-Mills, Roy Freeman, Stuart Isaacson, Beverly Karabin, Louis Kuritzky, Mark Lew, Phillip Low, Ali Mehdirad, Satish R. Raj, Steven Vernino, Horacio Kaufmann

Published in: Journal of Neurology | Issue 8/2017

Abstract

Neurogenic orthostatic hypotension (nOH) is common in patients with neurodegenerative disorders such as Parkinson’s disease, multiple system atrophy, pure autonomic failure, dementia with Lewy bodies, and peripheral neuropathies including amyloid or diabetic neuropathy. Due to the frequency of nOH in the aging population, clinicians need to be well informed about its diagnosis and management. To date, studies of nOH have used different outcome measures and various methods of diagnosis, thereby preventing the generation of evidence-based guidelines to direct clinicians towards ‘best practices’ when treating patients with nOH and associated supine hypertension. To address these issues, the American Autonomic Society and the National Parkinson Foundation initiated a project to develop a statement of recommendations beginning with a consensus panel meeting in Boston on November 7, 2015, with continued communications and contributions to the recommendations through October of 2016. This paper summarizes the panel members’ discussions held during the initial meeting along with continued deliberations among the panel members and provides essential recommendations based upon best available evidence as well as expert opinion for the (1) screening, (2) diagnosis, (3) treatment of nOH, and (4) diagnosis and treatment of associated supine hypertension.

Available only for authorised users

Low PA (2008) Prevalence of orthostatic hypotension. Clin Auton Res Off J Clin Auton Res Soc 18(Suppl 1):8–13. doi:10.1007/s10286-007-1001-3 CrossRef

Metzler M, Duerr S, Granata R, Krismer F, Robertson D, Wenning GK (2013) Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management. J Neurol 260(9):2212–2219. doi:10.1007/s00415-012-6736-7 CrossRefPubMed

Maule S, Milazzo V, Maule MM, Di Stefano C, Milan A, Veglio F (2012) Mortality and prognosis in patients with neurogenic orthostatic hypotension. Funct Neurol 27(2):101–106PubMedPubMedCentral

Gibbons CH, Freeman R (2015) Clinical implications of delayed orthostatic hypotension: A 10-year follow-up study. Neurology 85(16):1362–1367. doi:10.1212/WNL.0000000000002030 CrossRefPubMedPubMedCentral

Xin W, Lin Z, Mi S (2014) Orthostatic hypotension and mortality risk: a meta-analysis of cohort studies. Heart (British Cardiac Society) 100(5):406–413. doi:10.1136/heartjnl-2013-304121

Freeman R (2008) Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med 358(6):615–624CrossRefPubMed

Low PA, Singer W (2008) Management of neurogenic orthostatic hypotension: an update. Lancet Neurol 7(5):451–458CrossRefPubMedPubMedCentral

Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz IJ, Schondorf R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci 161(1–2):46–48. doi:10.1016/j.autneu.2011.02.004 CrossRefPubMed

Loavenbruck A, Sandroni P (2015) Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions. Curr Med Res Opin 31(11):2095–2104. doi:10.1185/03007995.2015.1087988 CrossRefPubMed

10.

Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y (2003) Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension 42(2):136–142CrossRefPubMed

11.

Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M, Fouad-Tarazi FM (1993) Neurogenic orthostatic hypotension: a double-blind, placebo- controlled study with midodrine. Am J Med 95(1):38–48CrossRefPubMed

12.

Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA (1997) Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, doubleblind multicenter study. Midodrine Study Group. JAMA 277(13):1046–1051CrossRefPubMed

13.

Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, Low PA (1998) A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51(1):120–124CrossRefPubMed

14.

Singer W, Sandroni P, Opfer-Gehrking TL, Suarez GA, Klein CM, Hines S, O’Brien PC, Slezak J, Low PA (2006) Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 63(4):513–518CrossRefPubMed

15.

Kaufmann H, Freeman R, Biaggioni I, Low P, Pedder S, Hewitt LA, Mauney J, Feirtag M, Mathias CJ, Investigators NOH (2014) Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 83(4):328–335. doi:10.1212/WNL.0000000000000615 CrossRefPubMedPubMedCentral

16.

Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H, Droxidopa I (2015) Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension 65(1):101–107. doi:10.1161/HYPERTENSIONAHA.114.04035 CrossRefPubMed

17.

Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G (2015) Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson’s disease (nOH306B). Mov Disord 30(5):646–654. doi:10.1002/mds.26086 CrossRefPubMed

18.

Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA (2003) Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 74(9):1294–1298CrossRefPubMedPubMedCentral

19.

Senard JM (2005) Pyridostigmine in the treatment of orthostatic hypotension. Clin Auton Res Off J Clin Auton Res Soc 15(6):421–422CrossRef

20.

Singer W, Opfer-Gehrking TL, Nickander KK, Hines SM, Low PA (2006) Acetylcholinesterase inhibition in patients with orthostatic intolerance. J Clin Neurophysiol 23(5):476–481CrossRefPubMed

21.

Provitera V, Nolano M, Pagano A (2006) Acetylcholinesterase inhibition and orthostatic hypotension. Clin Auton Res Off J Clin Auton Res Soc 16(2):136. doi:10.1007/s10286-006-0336-5 CrossRef

22.

Lahrmann H, Cortelli P, Hilz M, Mathias C, Struhal W, Tassinari M (2011) Orthostatic hypotension. In: Barnes MP, Brainin M, Gilhus NE (eds) European handbook of neurological management Vol. 1, 2nd edn. Wiley-Blackwell, Oxford, pp 469–475

23.

Bleasdale-Barr KM, Mathias CJ (1998) Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension. J R Soc Med 91(7):355–359CrossRefPubMedPubMedCentral

24.

Gibbons CH, Freeman R (2005) Orthostatic dyspnea: a neglected symptom of orthostatic hypotension. Clin Auton Res Off J Clin Auton Res Soc 15(1):40–44. doi:10.1007/s10286-005-0227-1 CrossRef

25.

Robertson D, Kincaid DW, Haile V, Robertson RM (1994) The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache. Clin Auton Res Off J Clin Auton Res Soc 4(3):99–103CrossRef

26.

Guaraldi P, Poda R, Calandra-Buonaura G, Solieri L, Sambati L, Gallassi R, Cortelli P (2014) Cognitive function in peripheral autonomic disorders. PLoS One 9(1):e85020. doi:10.1371/journal.pone.0085020 CrossRefPubMedPubMedCentral

27.

Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A (2016) Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology. doi:10.1212/wnl.0000000000003452 PubMed

28.

Shibao C, Grijalva CG, Raj SR, Biaggioni I, Griffin MR (2007) Orthostatic hypotension-related hospitalizations in the United States. Am J Med 120(11):975–980. doi:10.1016/j.amjmed.2007.05.009 CrossRefPubMed

29.

Low PA (2015) Neurogenic orthostatic hypotension: pathophysiology and diagnosis. Am J Manag Care 21(13 Suppl):s248–s257PubMed

30.

Davidson C, Smith D, Morgan DB (1976) Diurnal pattern of water and electrolyte excretion and body weight in idiopathic orthostatic hypotension. The effect of three treatments. Am J Med 61:709–715CrossRefPubMed

31.

Ikeda T, Matsubara T, Sato Y, Sakamoto N (1993) Circadian blood pressure variation in diabetic patients with autonomic neuropathy [see comments]. J Hypertens 11(5):581–587CrossRefPubMed

32.

Mann S, Bellamy GR, Hunyor SN, Raftery EB, Ingall T, Bannister R (1984) Supine hypertension, blood pressure variability and circadian rhythm in autonomic failure: the role of ambulatory intra- arterial monitoring. Clin Exp Pharmacol Physiol 11:347–350CrossRefPubMed

33.

Shibao C, Lipsitz LA, Biaggioni I, American Society of Hypertension Writing Group (2013) Evaluation and treatment of orthostatic hypotension. J Am Soc Hypertens 7(4):317–324. doi:10.1016/j.jash.2013.04.006 CrossRefPubMedPubMedCentral

34.

Gibbons CH, Freeman R (2006) Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 67(1):28–32. doi:10.1212/01.wnl.0000223828.28215.0b CrossRefPubMed

35.

Biaggioni I (2015) Treatment: special conditions: orthostatic hypotension. J Am Soc Hypertens 9(1):67–69. doi:10.1016/j.jash.2014.12.005 CrossRefPubMed

36.

White NJ (1980) Heart-rate changes on standing in elderly patients with orthostatic hypotension. Clin Sci 58(5):411–413CrossRefPubMed

37.

Poon IO, Braun U (2005) High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther 30(2):173–178. doi:10.1111/j.1365-2710.2005.00629.x CrossRefPubMed

38.

Gibbons CH, Freeman R (2015) Clinical implications of delayed orthostatic hypotension: A 10-year follow-up study. Neurology. doi:10.1212/WNL.0000000000002030 PubMedPubMedCentral

39.

Low PA, Tomalia VA, Park KJ (2013) Autonomic function tests: some clinical applications. J Clin Neurol 9(1):1–8. doi:10.3988/jcn.2013.9.1.1 CrossRefPubMedPubMedCentral

40.

Baschieri F, Calandra-Buonaura G, Doria A, Mastrolilli F, Palareti A, Barletta G, Solieri L, Guaraldi P, Martinelli P, Cortelli P (2015) Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage. Parkinsonism Relat Disord 21(5):477–482. doi:10.1016/j.parkreldis.2015.02.011 CrossRefPubMed

41.

Goldstein DS, Holmes C, Sharabi Y, Brentzel S, Eisenhofer G (2003) Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 60(8):1327–1332CrossRefPubMed

42.

Robertson D (2008) The pathophysiology and diagnosis of orthostatic hypotension. Clin Auton Res Off J Clin Auton Res Soc 18(Suppl 1):2–7CrossRef

43.

Freeman R (2003) Treatment of orthostatic hypotension. Semin Neurol 23(4):435–442CrossRefPubMed

44.

Weinberg AD, Minaker KL (1995) Dehydration:evaluation and management in older adults. Council on Scientific Affairs, American Medical Association. J Am Med Assoc 274(19):1552–1556CrossRef

45.

Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F, Diedrich A, Robertson RM, Biaggioni I, Robertson D (2000) The pressor response to water drinking in humans: a sympathetic reflex? Circulation 101(5):504–509CrossRefPubMed

46.

Shannon JR, Diedrich A, Biaggioni I, Tank J, Robertson RM, Robertson D, Jordan J (2002) Water drinking as a treatment for orthostatic syndromes. Am J Med 112(5):355–360CrossRefPubMed

47.

May M, Jordan J (2011) The osmopressor response to water drinking. Am J Physiol Regul Integr Comp Physiol 300(1):R40–R46. doi:10.1152/ajpregu.00544.2010 CrossRefPubMed

48.

Lipp A, Tank J, Franke G, Arnold G, Luft FC, Jordan J (2005) Osmosensitive mechanisms contribute to the water drinking-induced pressor response in humans. Neurology 65(6):905–907. doi:10.1212/01.wnl.0000176060.90959.36 CrossRefPubMed

49.

Raj SR, Biaggioni I, Black BK, Rali A, Jordan J, Taneja I, Harris PA, Robertson D (2006) Sodium paradoxically reduces the gastropressor response in patients with orthostatic hypotension. Hypertension 48(2):329–334. doi:10.1161/01.HYP.0000229906.27330.4f CrossRefPubMed

50.

Schroeder C, Bush VE, Norcliffe LJ, Luft FC, Tank J, Jordan J, Hainsworth R (2002) Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation 106(22):2806–2811CrossRefPubMed

51.

Jordan J, Shannon JR, Diedrich A, Black B, Robertson D, Biaggioni I (2004) Water potentiates the pressor effect of ephedra alkaloids. Circulation 109(15):1823–1825CrossRefPubMed

52.

Mathias CJ, Young TM (2004) Water drinking in the management of orthostatic intolerance due to orthostatic hypotension, vasovagal syncope and the postural tachycardia syndrome. Eur J Neurol 11(9):613–619CrossRefPubMed

53.

Claydon VE, Schroeder C, Norcliffe LJ, Jordan J, Hainsworth R (2006) Water drinking improves orthostatic tolerance in patients with posturally related syncope. Clin Sci 110(3):343–352CrossRefPubMed

54.

Kerstens MN, Kobold AC, Volmer M, Koerts J, Sluiter WJ, Dullaart RP (2011) Reference Values for Aldosterone–Renin Ratios in Normotensive Individuals and Effect of Changes in Dietary Sodium Consumption. Clin Chem 57(11):1607–1611. doi:10.1373/clinchem.2011.165662 CrossRefPubMed

55.

Mtinangi BL, Hainsworth R (1998) Early effects of oral salt on plasma volume, orthostatic tolerance, and baroreceptor sensitivity in patients with syncope. Clin Auton Res Off J Clin Auton Res Soc 8(4):231–235CrossRef

56.

Baas SJ, Endert E, Fliers E, Prummel MF, Wiersinga WM (2003) Establishment of reference values for endocrine tests. III: primary aldosteronism. The Netherlands J Med 61(2):37–43

57.

Kranzler HR, Cardoni A (1988) Sodium chloride treatment of antidepressant-induced orthostatic hypotension. J Clin Psychiatry 49:366–368PubMed

58.

Smith GD, Mathias CJ (1995) Postural hypotension enhanced by exercise in patients with chronic autonomic failure. QJM 88(4):251–256PubMed

59.

Zion AS, De Meersman R, Diamond BE, Bloomfield DM (2003) A home-based resistance-training program using elastic bands for elderly patients with orthostatic hypotension. Clin Auton Res Off J Clin Auton Res Soc 13(4):286–292. doi:10.1007/s10286-003-0117-3 CrossRef

60.

Figueroa JJ, Basford JR, Low PA (2010) Preventing and treating orthostatic hypotension: as easy as A, B, C. Cleve Clin J Med 77(5):298–306. doi:10.3949/ccjm.77a.09118 CrossRefPubMedPubMedCentral

61.

Pierangeli G, Provini F, Maltoni P, Barletta G, Contin M, Lugaresi E, Montagna P, Cortelli P (2001) Nocturnal body core temperature falls in Parkinson’s disease but not in Multiple-System Atrophy. Mov Disord 16(2):226–232CrossRefPubMed

62.

Wieling W, van Lieshout JJ, van Leeuwen AM (1993) Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res Off J Clin Auton Res Soc 3(1):57–65CrossRef

63.

ten Harkel AD, van Lieshout JJ, Wieling W (1992) Treatment of orthostatic hypotension with sleeping in the head- up tilt position, alone and in combination with fludrocortisone. J Intern Med 232(2):139–145CrossRefPubMed

64.

Henry R, Rowe J, O’Mahony D (1999) Haemodynamic analysis of efficacy of compression hosiery in elderly fallers with orthostatic hypotension [letter]. Lancet 354(9172):45–46CrossRefPubMed

65.

Denq JC, Opfer-Gehrking TL, Giuliani M, Felten J, Convertino VA, Low PA (1997) Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res Off J Clin Auton Res Soc 7(6):321–326CrossRef

66.

Smit AA, Wieling W, Fujimura J, Denq JC, Opfer-Gehrking TL, Akarriou M, Karemaker JM, Low PA (2004) Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res Off J Clin Auton Res Soc 14(3):167–175

67.

Okamoto LE, Diedrich A, Baudenbacher FJ, Harder R, Whitfield JS, Iqbal F, Gamboa A, Shibao CA, Black BK, Raj SR, Robertson D, Biaggioni I (2016) Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine. Hypertension. doi:10.1161/hypertensionaha.116.07199

68.

Jansen RW, Lipsitz LA (1995) Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 122(4):286–295CrossRefPubMed

69.

Puisieux F, Boumbar Y, Bulckaen H, Bonnin E, Houssin F, Dewailly P (1999) Intraindividual variability in orthostatic blood pressure changes among older adults: the influence of meals. J Am Geriatr Soc 47(11):1332–1336CrossRefPubMed

70.

Puvi-Rajasingham S, Mathias CJ (1996) Effect of meal size on post-prandial blood pressure and on postural hypotension in primary autonomic failure. Clin Auton Res Off J Clin Auton Res Soc 6(2):111–114CrossRef

71.

Berry MK, Russo A, Wishart JM, Tonkin A, Horowitz M, Jones KL (2003) Effect of solid meal on gastric emptying of, and glycemic and cardiovascular responses to, liquid glucose in older subjects. Am J Physiol Gastrointest Liv Physiol 284(4):G655–G662. doi:10.1152/ajpgi.00163.2002 CrossRef

72.

Jansen RW, Peeters TL, Van Lier HJ, Hoefnagels WH (1990) The effect of oral glucose, protein, fat and water loading on blood pressure and the gastrointestinal peptides VIP and somatostatin in hypertensive elderly subjects. Eur J Clin Invest 20(2):192–198CrossRefPubMed

73.

Onrot J, Goldberg MR, Biaggioni I, Hollister AS, Kingaid D, Robertson D (1985) Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med 313(9):549–554. doi:10.1056/nejm198508293130905 CrossRefPubMed

74.

Shibao C, Gamboa A, Diedrich A, Dossett C, Choi L, Farley G, Biaggioni I (2007) Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension 50(1):54–61. doi:10.1161/hypertensionaha.107.091355 CrossRefPubMed

75.

Ando Y, Asahara K, Obayashi K, Suhr O, Yonemitsu M, Yamashita T, Tashima K, Uchino M, Ando M (1996) Autonomic dysfunction and anemia in neurologic disorders. J Auton Nerv Syst 61(2):145–148CrossRefPubMed

76.

Beitzke M, Pfister P, Fortin J, Skrabal F (2002) Autonomic dysfunction and hemodynamics in vitamin B12 deficiency. Auton Neurosci 97(1):45–54CrossRefPubMed

77.

Skrabal F (2004) Syncope, falls and cobalamin deficiency in the old population. Clin Auton Res Off J Clin Auton Res Soc 14(2):60–66. doi:10.1007/s10286-004-0179-x CrossRef

78.

Parsaik AK, Singh B, Altayar O, Mascarenhas SS, Singh SK, Erwin PJ, Murad MH (2013) Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med 28(11):1496–1503. doi:10.1007/s11606-013-2520-3 CrossRefPubMedPubMedCentral

79.

McClellan KJ, Wiseman LR, Wilde MI (1998) Midodrine. A review of its therapeutic use in the management of orthostatic hypotension. Drugs Aging 12(1):76–86CrossRefPubMed

80.

Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R (2003) Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108(6):724–728. doi:10.1161/01.cir.0000083721.49847.d7 CrossRefPubMed

81.

Campbell IW, Ewing DJ, Clarke BF (1975) 9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes 24:381–384CrossRefPubMed

82.

Decaux G (1979) Fludrocortisone in orthostatic hypotension [letter]. N Engl J Med 301:1121–1122CrossRefPubMed

83.

Watt SJ, Tooke JE, Perkins CM, Lee MR (1981) The treatment of idiopathic orthostatic hypotension: a combined fludrocortisone and flurbiprofen regime. Q J Med 50:205–212PubMed

84.

van Lieshout JJ, ten Harkel AD, Wieling W (2000) Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res Off J Clin Auton Res Soc 10(1):35–42CrossRef

85.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith Jr SC, Svetkey LP, Taler SJ, Townsend RR, Wright Jr JT, Narva AS, Ortiz E (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507–520. doi:10.1001/jama.2013.284427 CrossRefPubMed

86.

Jordan J, Biaggioni I (2002) Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension. J Clin Hypertens (Greenwich) 4(2):139–145CrossRef

Title: The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension
Authors: Christopher H. Gibbons
Peter Schmidt
Italo Biaggioni
Camille Frazier-Mills
Roy Freeman
Stuart Isaacson
Beverly Karabin
Louis Kuritzky
Mark Lew
Phillip Low
Ali Mehdirad
Satish R. Raj
Steven Vernino
Horacio Kaufmann
Publication date: 01-08-2017
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 8/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-016-8375-x

At a glance: The STEP trials

Springer Medicine

The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2017

Recent advances in epilepsy

Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome

Andreas Vesalius (1514–1564)

Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach

The clinical heterogeneity of drug-induced myoclonus: an illustrated review

The role of TSPO PET in assessing neuroinflammation